Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
0.6400
-0.0141 (-2.16%)
At close: May 8, 2026, 4:00 PM EDT
0.6535
+0.0135 (2.11%)
After-hours: May 8, 2026, 7:56 PM EDT
Citius Pharmaceuticals Market Cap
Citius Pharmaceuticals has a market cap or net worth of $17.35 million as of May 8, 2026. Its market cap has increased by 131.31% in one year.
Market Cap
17.35M
Enterprise Value
11.46M
1-Year Change
131.31%
Ranking
Category
Stock Price
$0.64
Market Cap Chart
Since July 6, 2017, Citius Pharmaceuticals's market cap has decreased from $30.70M to $17.35M, a decrease of -43.49%. That is a compound annual growth rate of -6.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 14.30M | -11.18% |
| Dec 31, 2025 | 16.10M | -47.90% |
| Dec 31, 2024 | 30.90M | -74.31% |
| Dec 29, 2023 | 120.30M | 4.16% |
| Dec 30, 2022 | 115.50M | -48.64% |
| Dec 31, 2021 | 224.90M | 296.65% |
| Dec 31, 2020 | 56.70M | 92.20% |
| Dec 31, 2019 | 29.50M | 59.46% |
| Dec 31, 2018 | 18.50M | -42.19% |
| Dec 29, 2017 | 32.00M | 4.23% |
| Jul 6, 2017 | 30.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Quince Therapeutics | 19.89M |
| Lipocine | 19.50M |
| SeaStar Medical Holding | 19.45M |
| Cocrystal Pharma | 19.44M |
| OSR Holdings | 19.34M |
| Cadrenal Therapeutics | 18.99M |
| Theriva Biologics | 17.53M |
| Traws Pharma | 17.27M |